In addition, KLF4 was identified as a putative upstream regulator of drug resistance in ovarian cancer and together with ST3GAL5, SYNE1, CXCL8, HERC5, FOSL1, ARRDC4 merits further studies. This evidence concerns the gene ARRDC4 and ovarian carcinoma.